Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26788020)

Published in Mediators Inflamm on December 14, 2015

Authors

Jeffrey K Actor1

Author Affiliations

1: UTHealth, Department of Pathology, University of Texas-Houston Medical School, Houston, TX 77030, USA; Program in Immunology, Graduate School of Biomedical Sciences, Houston, TX 77030, USA.

Articles cited by this

(truncated to the top 100)

Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol (2007) 8.92

Herd immunity: history, theory, practice. Epidemiol Rev (1993) 5.44

Who puts the tubercle in tuberculosis? Nat Rev Microbiol (2006) 4.01

The C-type lectin superfamily in the immune system. Immunol Rev (1998) 3.63

Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA (2009) 3.34

Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med (2009) 3.19

Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature (1992) 3.19

Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol (2012) 2.86

A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol (2001) 2.52

Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol (2010) 2.38

The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev (2008) 2.36

Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med (2010) 2.26

Biological role of lactoferrin. Arch Dis Child (1992) 2.15

MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog (2009) 2.12

Lactoferrin: molecular structure and biological function. Annu Rev Nutr (1995) 2.05

Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation. J Exp Med (2009) 2.03

Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis (Edinb) (2007) 1.95

Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol Rev (2011) 1.72

The role of surface in the biological activities of trehalose 6,6'-dimycolate. Surface properties and development of a model system. J Biol Chem (1981) 1.66

Cord factor trehalose 6,6'-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology (2003) 1.55

Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med (1999) 1.55

Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci (2006) 1.53

What's good for the host is good for the bug. Trends Microbiol (2005) 1.47

Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol Microbiol (2003) 1.45

Lactoferrin as a natural immune modulator. Curr Pharm Des (2009) 1.40

In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J Immunol (2009) 1.38

Trehalose 6,6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am J Pathol (2006) 1.35

The balance between protective and pathogenic immune responses in the TB-infected lung. Nat Immunol (2015) 1.30

Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis (Edinb) (2011) 1.25

Influence of trehalose 6,6'-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology (2002) 1.22

Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids. Ann Clin Lab Sci (1993) 1.17

Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice. Infect Immun (2001) 1.16

Granulomatous hypersensitivity to trehalose-6,6'-dimycolate (cord factor) in mice infected with BCG. Infect Immun (1973) 1.15

Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand J Immunol (2000) 1.15

A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response. Microbiology (2008) 1.15

Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell Immunol (2006) 1.14

The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria? Clin Dev Immunol (2012) 1.14

A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential. Infect Immun (2004) 1.12

Lactoferrin, a key molecule in immune and inflammatory processes. Biochem Cell Biol (2011) 1.09

Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun (2000) 1.08

Mincle is a long sought receptor for mycobacterial cord factor. J Exp Med (2009) 1.06

Identification of the physiologically active state of the mycobacterial glycolipid trehalose 6,6'-dimycolate and the role of fibrinogen in the biologic activities of trehalose 6,6'-dimycolate monolayers. J Immunol (1982) 1.05

Milk-derived proteins and peptides of potential therapeutic and nutritive value. J Exp Ther Oncol (2007) 1.04

Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6'-dimycolate. J Interferon Cytokine Res (2000) 1.04

Mycobacterial glycolipid trehalose 6,6'-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes. Microbiology (2007) 1.02

TB, or not TB: that is the question -- does TLR signaling hold the answer? J Clin Invest (2004) 1.01

The formation of the granuloma in tuberculosis infection. Semin Immunol (2014) 1.00

Failure of CD1D-/- mice to elicit hypersensitive granulomas to mycobacterial cord factor trehalose 6,6'-dimycolate. J Interferon Cytokine Res (2004) 0.99

Lactoferrin immunomodulation of DTH response in mice. Int Immunopharmacol (2002) 0.98

Apoptosis in mycobacterium tuberculosis infection in mice exhibiting varied immunopathology. J Pathol (2000) 0.98

Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis. Int Immunopharmacol (2005) 0.98

Extravascular coagulation and fibrinolysis in murine lung inflammation induced by the mycobacterial cord factor trehalose-6,6'-dimycolate. Am J Respir Crit Care Med (1994) 0.98

Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology (2006) 0.98

Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology (1995) 0.97

Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice. Inflammation (2000) 0.97

Pathogenesis of post primary tuberculosis: immunity and hypersensitivity in the development of cavities. Ann Clin Lab Sci (2014) 0.96

Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response. Glycoconj J (2008) 0.95

A role for complement C5 in organism containment and granulomatous response during murine tuberculosis. Scand J Immunol (2001) 0.93

Lactoferrin and the inflammatory response. Adv Exp Med Biol (1994) 0.93

Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate. Scand J Immunol (2005) 0.92

Relationship of survival, organism containment, and granuloma formation in acute murine tuberculosis. J Interferon Cytokine Res (1999) 0.92

Comparative analysis of the site-specific N-glycosylation of human lactoferrin produced in maize and tobacco plants. Eur J Biochem (2003) 0.91

Lactoferrin and immunologic dissonance: clinical implications. Arch Immunol Ther Exp (Warsz) (2002) 0.91

Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Med Microbiol Immunol (2007) 0.91

Enhanced immune response in Mycobacterium bovis bacille calmette guerin (BCG)-infected IL-10-deficient mice. Clin Chem Lab Med (2002) 0.90

Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages. Biochimie (2008) 0.90

Prostaglandin E2 down-regulates viable Bacille Calmette-Guérin-induced macrophage cytotoxicity against murine bladder cancer cell MBT-2 in vitro. Clin Exp Immunol (2002) 0.90

Immunomodulatory effects of lactoferrin. Acta Pharmacol Sin (2014) 0.90

Lactoferrin in health and disease. Postepy Hig Med Dosw (Online) (2007) 0.90

CD3+ cells transfer the hypersensitive granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate in mice. Microbiology (2006) 0.90

Characterization of glycans in a lactoferrin isoform, lactoferrin-a. J Dairy Sci (2001) 0.89

Bovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cells. PLoS One (2011) 0.88

A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice. Vaccine (2009) 0.87

Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection--the double-edged sword? Biomed Res Int (2013) 0.87

Iron-mediated dismutation of superoxide anion augments antigen-induced allergic inflammation: effect of lactoferrin. Postepy Hig Med Dosw (Online) (2007) 0.87

Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis. Vaccine (2007) 0.87

Dysregulated response to mycobacterial cord factor trehalose-6,6'-dimycolate in CD1D-/- mice. J Interferon Cytokine Res (2001) 0.86

Immunostimulatory activity of lactotransferrin and maturation of CD4- CD8- murine thymocytes. Immunol Lett (1991) 0.86

The adjuvant activity of lactoferrin in the generation of DTH to ovalbumin can be inhibited by bovine serum albumin bearing alpha-D-mannopyranosyl residues. Cell Mol Biol Lett (2002) 0.86

Lactoferrin modulation of BCG-infected dendritic cell functions. Int Immunol (2009) 0.86

Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis. J Clin Immunol (2014) 0.85

Lactoferrin modulation of antigen-presenting-cell response to BCG infection. Postepy Hig Med Dosw (Online) (2007) 0.84

The gut. A key metabolic organ protected by lactoferrin during experimental systemic inflammation in mice. Adv Exp Med Biol (1998) 0.84

Lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c). Tuberculosis (Edinb) (2009) 0.83

11beta-hydroxysteroid dehydrogenases are regulated during the pulmonary granulomatous response to the mycobacterial glycolipid trehalose-6,6'-dimycolate. Neuroimmunomodulation (2009) 0.83

Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology. Tuberculosis (Edinb) (2011) 0.83

Heat-killed BCG induces biphasic cyclooxygenase 2+ splenic macrophage formation--role of IL-10 and bone marrow precursors. J Leukoc Biol (2006) 0.83

Mycobacterium tuberculosis subverts the TLR-2-MyD88 pathway to facilitate its translocation into the cytosol. PLoS One (2014) 0.83

Cytokine mRNA expression and serum cortisol evaluation during murine lung inflammation induced by Mycobacterium tuberculosis. Comb Chem High Throughput Screen (2000) 0.83

Regulatory effects of lactoferrin and lipopolysaccharide on LFA-1 expression on human peripheral blood mononuclear cells. Arch Immunol Ther Exp (Warsz) (1999) 0.82

Trehalose 6,6'-dimycolate--a coat to regulate tuberculosis immunopathogenesis. Tuberculosis (Edinb) (2013) 0.82

Lactoferrin for prevention of neonatal sepsis. Biometals (2014) 0.81

Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response. Transl Res (2010) 0.81

Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin. Int Immunopharmacol (2004) 0.80

Mycobacterial glycolipid cord factor trehalose 6,6'-dimycolate causes a decrease in serum cortisol during the granulomatous response. Neuroimmunomodulation (2003) 0.80

LF immunomodulatory strategies: mastering bacterial endotoxin. Biochem Cell Biol (2012) 0.79

Relative contribution of IL-1α, IL-1β and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG. Immun Inflamm Dis (2013) 0.79

Bovine lactoferrin enhances proliferation of human peripheral blood lymphocytes and induces cytokine production in whole blood cultures. Adv Clin Exp Med (2015) 0.79

Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression. J Biotechnol (2013) 0.79

Lactoferrin stimulates killing and clearance of bacteria but does not prevent mortality of diabetic mice. Arch Immunol Ther Exp (Warsz) (2001) 0.78